Cover Image
市場調查報告書

基於片段的藥物研發市場:各服務元件 (片段篩檢及片段最佳化) 、各終端用戶 - 全球產業分析,規模,佔有率,成長,趨勢,及2015∼2023年的預測

Fragment-based Drug Discovery Market By Service Component (Fragment screening and Fragment Optimization), By End-user - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 344583
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
基於片段的藥物研發市場:各服務元件 (片段篩檢及片段最佳化) 、各終端用戶 - 全球產業分析,規模,佔有率,成長,趨勢,及2015∼2023年的預測 Fragment-based Drug Discovery Market By Service Component (Fragment screening and Fragment Optimization), By End-user - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2015年10月14日 內容資訊: 英文 111 Pages
簡介

本報告提供全球基於片段的藥物研發市場相關調查,提供您市場概要與各服務元件,各終端用戶趨勢,2015∼2023年預測,及各地區趨勢,以及參與企業簡介等資訊。

第1章 序論

第2章 摘要整理

第3章 基於片段的藥物研發 (FBDD) 市場概要

  • 簡介
  • 活動影響分析
  • 未來趨勢與發展
  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 波特五力分析
  • 近幾年的發展
  • 個案歷史
  • 市場佔有率
  • 市場魅力度分析

第4章 各服務元件市場

  • 簡介
  • FBDD和HTS的比較分析
  • 全球片段篩檢市場收益:2013∼2023年
  • 全球片段最佳化市場收益:2013∼2023年

第5章 市場區隔:各終端用戶

  • 簡介
  • 生物醫藥品企業
  • CRO
  • 學術研究機關

第6章 各地區市場

  • 全球的概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第7章 企業簡介

  • Astex Pharmaceuticals
  • Alveus Pharmaceuticals Pvt. Ltd.
  • Beactica AB
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Emerald BioStructures, Inc.
  • Evotec AG
  • Kinetic Discovery Limited
  • Proteros Fragments GmbH
  • Sprint Bioscience
  • Structure Based Design, Inc.
  • Sygnature Discovery
目錄

The increasing search for new drugs to treat complicated medical problems has led to a surge in the global fragment-based drug discovery market. Furthermore, the growth of the global fragment-based drug discovery market has also led to dominance of biopharmaceutical companies, as the market requires a system for identification of lead compounds in the process of drug discovery.

The report published by Transparency Market Research on the global fragment-based drug discovery market gives a comprehensive overview of the important dynamics and trends. The report assesses the threat from new entrants, threat of substitute products or services, bargaining power of customers, bargaining power of suppliers, and the intensity of competitive rivalry with the help of a Porter's five forces analysis. Furthermore, it also evaluates the strengths, weaknesses, opportunities, and threats of the market with the help of a SWOT analysis. The report gives a clear understanding of the competitive landscape and segmentation of the market and an overview of the global fragment-based drug discovery market to enable its readers to make well-informed business decisions.

Overview of Global Fragment-Based Drug Discovery Market

The drivers for the global fragment-based drug discovery market are its time-saving attributes and quick access to biophysical fragment screening techniques. Fragment-based drug discovery has become a method of designing unique molecules. This technique uses smaller ‘fragments or ligands', which have lower molecular weights. The main restraint on the global fragment-based drug discovery market is the weak potency of a few compounds that are derived from fragment screening. The other conspicuous restraint on this market is the need for special ‘fragment libraries' for conducting research.

The global fragment-based drug discovery market has been segmented into fragment screening and fragment optimization. The fragment screening segment is further sub-segmented into biophysical techniques and non-biophysical techniques. Biophysical techniques include isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, fluorescence polarization (FP), differential scanning fluorimetry (DSF), surface plasmon resonance, X-ray crystallography, assay (thermal shift), biolayer interferometry, capillary electrophoresis, mass spectrometry, and others (biochemical assays). The end-use applications encouraging the growth of this market are CROs, biopharmaceutical companies, and academic and research institutions. Geographically, the global fragment-based drug discovery market is divided into regions such as North America, Asia Pacific, Europe, Latin America, and Rest of the World.

North America dominated the global fragment-based drug discovery market due to growing awareness about this sector and the high level of its adoption by pharmaceutical companies. However, in the coming years, the Asia Pacific fragment-based drug discovery market will witness phenomenal growth due to the growing number of research and development activities.

Companies Mentioned in the Global Fragment-Based Drug Discovery Market Report

The important players in the global fragment-based drug discovery market are Astex Pharmaceuticals, Beactica AB, Structure Based Design, Inc., Alveus Pharmaceuticals Pvt. Ltd., Emerald BioStructures, Inc., Evotec AG, Crown Bioscience, Inc., Kinetic Discovery Limited, Sprint Bioscience, Proteros Fragments GmbH, Charles River Laboratories International, Inc., and Sygnature Discovery.

The global fragment-based drug discovery market has been segmented as follows:

Fragment-Based Drug Discovery Market, by Services Component

  • Fragment Screening
    • Biophysical Techniques
      • Nuclear Magnetic Resonance (NMR) Spectroscopy
      • Differential scanning Fluorimetry (DSF) Assay (Thermal Shift)
      • Fluorescence Polarization (FP)
      • Isothermal Titration Calorimetry (ITC)
      • X-ray Crystallography
      • Surface Plasmon Resonance
      • Biolayer Interferometry
      • Mass Spectrometry
      • Capillary Electrophoresis
      • Others (Biochemical Assays)
    • Non-biophysical Techniques
  • Fragment Optimization

Fragment-Based Drug Discovery Market, by End-user

  • Biopharmaceutical Companies
  • CROs
  • Academic and Research Institutions

Fragment-Based Drug Discovery Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Australia
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Rest of the World (RoW)

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Research Methodology: Assumptions

Chapter 2 - Executive Summary

  • 2.1. Global Fragment-based Drug Discovery Market, Estimates and Forecast, By Revenue, 2013-2023 (US$ Mn)
  • 2.2. Global Fragment-based Drug Discovery Market Revenue, by Services, 2014 (US$ Mn)
  • 2.3. Global Fragment-based Drug Discovery Market Revenue, by End-user, 2014 (US$ Mn)
  • 2.4. Global Market Share, by Geography, 2014 and 2023 (Value %)
  • 2.5. Fragment-based Drug Discovery Market Snapshot

Chapter 3 - Fragment-based Drug Discovery Market Overview

  • 3.1. Introduction
    • 3.1.1. Hit to Lead
    • 3.1.2. Progression to Candidates from Fragment Leads
  • 3.2. Event Impact Analysis
  • 3.3. Future Trends and Developments
  • 3.4. Market Drivers
    • 3.4.1. Simpler and less time consuming technique
    • 3.4.2. Streamlining and easy access to advanced biophysical techniques
  • 3.5. Restraints
    • 3.5.1. Lower level of potency in few of the compounds derived from fragment screening
    • 3.5.2. Requirement of high protein and unique fragment library for conducting studies
  • 3.6. Opportunities
    • 3.6.1. Merging of computational biology with biophysical techniques
    • 3.6.2. Emerging economies to offer sustained growth opportunities
  • 3.7. Porter's Five Forces Analysis
  • 3.8. Recent Developments in Fragment-based Drug Discovery
  • 3.9. Fragment-based Drug Discovery: Case Histories
  • 3.10. Market Share - Fragment-based Drug Discovery Market (2014) (%)
  • 3.11. Market Attractiveness Analysis - Fragment-based Drug Discovery Market

Chapter 4 - Market Segmentation - By Services Component

  • 4.1. Introduction
  • 4.2. Comparative Analysis of FBDD and HTS
  • 4.3. Global Fragment Screening Market Revenue for FBDD, 2013 - 2023 (US$ Mn)
    • 4.3.1. Global Biophysical Techniques Market for FBDD (US$ Mn), 2013 - 2023)
      • 4.3.1.1. Global NMR Spectroscopy Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.2. Global DSF Assay Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.3. Global Fluorescence Polarization (FP) Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.4. Global Isothermal Titration Calorimetry (ITC) Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.5. Global X-ray Crystallography Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.6. Global SPR Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.7. Global Biolayer Interferometry Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.8. Global Mass Spectrometry (MS) Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.9. Global Capillary Electrophoresis (CE) Market Revenue for FBDD, 2013-2023 (US$ Mn)
      • 4.3.1.10. Global Other (Biochemical Assays) Market Revenue for FBDD, 2013-2023 (US$ Mn)
    • 4.3.2. Global Non-biophysical Techniques Market Revenue for FBDD, 2013-2023 (US$ Mn)
  • 4.4. Global Fragment Optimization Market Revenue for FBDD, 2013-2023 (US$ Mn)

Chapter 5 - Market Segmentation - By End-user

  • 5.1. Introduction
  • 5.2. Global Market for Fragment-based Drug Discovery in Biopharmaceutical Companies, 2013-2023 (US$ Mn)
  • 5.3. Global Market for Fragment-based Drug Discovery in CROs, 2013-2023 (US$ Mn)
  • 5.4. Global Market for Fragment-based Drug Discovery in Academic and Research Institutions, 2013-2023 (US$ Mn)

Chapter 6 - Fragment-based Drug Discovery Market - Regional Analysis

  • 6.1. Global Overview
  • 6.2. North America Fragment-based Drug Discovery Market Overview
    • 6.2.1. U.S. Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
    • 6.2.2. Canada Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
  • 6.3. Europe Fragment-based Drug Discovery Market Overview
    • 6.3.1. Germany Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
    • 6.3.2. U.K. Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
    • 6.3.3. Rest of Europe Fragment-based Drug Discovery Market Revenue, 2013-2023 (US$ Mn)
  • 6.4. Asia Pacific Fragment-based Drug Discovery Market Revenue, 2013-2023 (US$ Mn)
    • 6.4.1. Japan Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
    • 6.4.2. Australia Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
    • 6.4.3. Rest of Asia Pacific Fragment-based Drug Discovery Market Revenue, 2013-2023 (US$ Mn)
  • 6.5. LATAM Fragment-based Drug Discovery Market Revenue, 2013-2023 (US$ Mn)
    • 6.5.1. Brazil Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
    • 6.5.2. Rest of LATAM Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn)
  • 6.6. RoW Fragment-based Drug Discovery Market Revenue, 2013-2023 (US$ Mn)

Chapter 7 - Company Profiles

  • 7.1. Astex Pharmaceuticals
  • 7.2. Alveus Pharmaceuticals Pvt. Ltd.
  • 7.3. Beactica AB
  • 7.4. Charles River Laboratories International, Inc.
  • 7.5. Crown Bioscience, Inc.
  • 7.6. Emerald BioStructures, Inc.
  • 7.7. Evotec AG
  • 7.8. Kinetic Discovery Limited
  • 7.9. Proteros Fragments GmbH
  • 7.10. Sprint Bioscience
  • 7.11. Structure Based Design, Inc.
  • 7.12. Sygnature Discovery
Back to Top